ArunA Bio fetches $13 mln
Athens, Georgia-based ArunA Bio Inc, a developer of neural exosomes for the treatment of neurodegenerative diseases, has raised $13 million in financing. The backers included Eshelman Ventures.
25 July 2019•1 min read
Athens, Georgia-based ArunA Bio Inc, a developer of neural exosomes for the treatment of neurodegenerative diseases, has raised $13 million in financing. The backers included Eshelman Ventures.
